domoreforln.com redirects to benlystahcp.com. This page describes the site that domain now serves; the primary profile lives at benlystahcp.com.
AI visibility score
4.0/ 10Fair

#241,548 of 925,306 in Healthcare

As of 2026-08-01 · Engagemii indexCheck another site →Live terminal →

AI Visibility Scorecard

Efficacy for Lupus Nephritis

Efficacy for Lupus Nephritis

Unclaimed

domoreforln.com · Healthcare

Borderline visible. AI bots can crawl Efficacy for Lupus Nephritis, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.

AI engines read this profile 7 times

Claude · Apple Intelligence · Meta AI · ShapBot

#241,548 of 925,306 in Healthcare for AI visibility

19

AI Naming Predictability

i

Rarely named · 19/100

Healthcare average 11

Top 19% of Healthcare

See what's behind this score →

4

AEO Visibility

i

Borderline · 4/10

Healthcare average 4.0

See what's behind this score →

-

Network Authority

i

Not connected yet

0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.

See what's behind this score →

0

Muse Index Score

i

AI agent readiness

Not agent-ready · 0/100

Healthcare average 18

See what's behind this score →

0

AI Adoption

i

None detected · 0/100

Healthcare average 0

See what's behind this score →

Share

About Efficacy for Lupus Nephritis

from domoreforln.com

Review BENLYSTA (belimumab) efficacy for lupus nephritis, including real-world data. See how BENLYSTA may improve key clinical outcomes in lupus nephritis patients.

Company ·
Efficacy for Lupus Nephritis
Website ·
domoreforln.com
Industry ·
Healthcare
Site status ·
Live (The website showed an active business site when last checked (Oct 31, 2026).)
Last scored ·
Aug 1, 2026

The 6 signals AI reads

Strong · Good · Fair · Weak

Structured Data

Weak

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

Strong

Clear headings and answer-style content.

Entity Clarity

Strong

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

Good

Experience, Expertise, Authority, Trust markers.

Technical AEO

Good

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

Good

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

Good

Inbound links from other sites.

Domain Authority

Weak

Little domain authority yet.

Reference Presence

Weak

Not in AI knowledge graphs yet.

News & Press

Weak

No press coverage found yet.

Community

Weak

No community discussion yet.

Social Mentions

Weak

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 4/10, Efficacy for Lupus Nephritis is crawlable but under-signaled - fixable, and the signals above are where to start.

Is this your brand?

✓

The exact fixes for Efficacy for Lupus Nephritis

✓

Which AI engines already crawl you

✓

Free AI bot monitoring: see every AI crawler that visits you

Claim your page free

Already have an account? Sign in

Picked for Efficacy for Lupus Nephritis: How-To

How to Get Your Company Named by ChatGPT, Gemini, and Claude

When a buyer asks ChatGPT which company to use, two different things can happen. ChatGPT can name a company in its answer. Or it can link to a web page as a source. Most advice about AI visibility is about the second one. Our data says the first one is what matters.

Continue reading in your free Engagemii portal

Sign up free to read the full article and get your AEO fix list for Efficacy for Lupus Nephritis.

Source & Attribution

Scored by Engagemii on August 1, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/domoreforln

Cite this score: Engagemii (2026). "AEO Score for Efficacy for Lupus Nephritis." Retrieved from https://engagemii.com/aeo/brands/domoreforln

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform